INTELLIGENT BIO SOLUTIONS INC. Stock-Based Compensation
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Stock-Based Compensation of $195.21 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $97.43K, a 711.91% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $24.20K, a 101.70% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $61.58K, a 413.12% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $12.00K, a 94.06% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2026 was $195.21K, a 18.00% decline from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $238.04K, a 3.28% increase from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $230.50K, a 11.35% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $260.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $97.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $121.63K derived: sum of 2 quarters · filed 2026-08-19 | $183.21K derived: sum of 3 quarters · filed 2026-08-19 | $195.21K 10-K · filed 2026-08-19 |
| 2026-03-31 | $24.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $85.78K derived: sum of 2 quarters · filed 2026-05-13 | $97.78K 10-Q · filed 2026-05-13 | $109.78K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $61.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $73.58K 10-Q · filed 2026-02-12 | $85.58K derived: sum of 3 quarters · filed 2026-08-19 | $97.58K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $12.00K 10-Q · filed 2025-11-12 | $24.00K derived: sum of 2 quarters · filed 2026-08-19 | $36.00K derived: sum of 3 quarters · filed 2026-08-19 | $48.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $24.00K derived: sum of 2 quarters · filed 2026-08-19 | $36.00K derived: sum of 3 quarters · filed 2026-08-19 | $238.04K 10-K · filed 2026-08-19 |
| 2025-03-31 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $24.00K derived: sum of 2 quarters · filed 2026-05-13 | $226.04K 10-Q · filed 2026-05-13 | $238.24K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $214.04K 10-Q · filed 2026-02-12 | $226.24K derived: sum of 3 quarters · filed 2026-02-12 | $444.54K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $202.04K 10-Q · filed 2025-11-12 | $214.24K derived: sum of 2 quarters · filed 2025-11-12 | $432.54K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $12.19K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $230.50K derived: sum of 2 quarters · filed 2025-08-15 | $230.50K 10-K · filed 2025-08-15 | |
| 2024-03-31 | $218.31K 10-Q · filed 2024-05-08 | $218.31K 10-Q · filed 2025-05-13 | ||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $0.00 derived: sum of 2 quarters · filed 2024-09-18 | $260.00K derived: sum of 3 quarters · filed 2024-09-18 | $260.00K 10-K · filed 2024-09-18 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $260.00K derived: sum of 2 quarters · filed 2024-05-08 | $260.00K 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $260.00K 10-K · filed 2023-08-23 | $260.00K 10-Q · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |